Search

Your search keyword '"Overi D"' showing total 72 results

Search Constraints

Start Over You searched for: Author "Overi D" Remove constraint Author: "Overi D"
72 results on '"Overi D"'

Search Results

1. Role of ductular reaction and ductular–canalicular junctions in identifying severe primary biliary cholangitis

3. Accuracy of Liver Stiffness Measurement in assessing liver fibrosis in naïve patients with Primary Biliary Cholangitis

4. Accuracy of Transient Elastography in assessing fibrosis at diagnosis in naïve patients with Primary Biliary Cholangitis: a dual cut-off approach

5. DCLK1, a putative novel stem cell marker in human cholangiocarcinoma

7. Ductular reaction, intermediate hepatocytes and fibrosis extension correlate with prediction of treatment failure to ursodeoxycholic acid in primary biliary cholangitis

8. FRI-011-Ductular reaction, intermediate hepatocites and fibrosis extension correlate with prediction of treatment failure to ursodeoxycholic acid in primary biliary cholangitis

10. PC.01.6 HUMAN DUODENAL SUBMUCOSAL GLANDS CONTAIN STEM CELLS WITH POTENTIAL FOR LIVER AND PANCREATIC FATES

11. Human duodenal submucosal glands contain stem cells with potential for liver and pancreatic regenerative medicine

12. Ductular reaction, intermediate hepatocytes and fibrosis extension correlate with prediction of treatment failure to ursodeoxycholic acid in primary biliary cholangitis

13. The FXR agonist obeticholic acid inhibits the cancerogenic potential of human cholangiocarcinoma

15. Different micro-environtmental factors induce proliferation, epithelial-mesenchymal transition (EMT) and senescence of primary cultures of human biliary tree stem/progenitor cells (hBTSCs), recapitulating the pathological features typical of human cholangiopathies

18. DCLK1, a putative novel stem cell marker in human cholangiocarcinoma

19. Accuracy of Transient Elastography in Assessing Fibrosis at Diagnosis in Naïve Patients With Primary Biliary Cholangitis: A Dual Cut-Off Approach

20. Accuracy of liver stiffness measurement in assessing liver fibrosis in naive patients with primary biliary cholangitis

21. The FXR agonist obeticholic acid inhibits the cancerogenic potential of human cholangiocarcinoma

22. FRI-011-Ductular reaction, intermediate hepatocites and fibrosis extension correlate with prediction of treatment failure to ursodeoxycholic acid in primary biliary cholangitis

23. Oleuropein, a Component of Extra Virgin Olive Oil, Improves Liver Steatosis and Lobular Inflammation by Lipopolysaccharides-TLR4 Axis Downregulation.

24. Recommendations on maximising the clinical value of tissue in the management of patients with intrahepatic cholangiocarcinoma.

25. Molecular portraits of patients with intrahepatic cholangiocarcinoma who diverge as rapid progressors or long survivors on chemotherapy.

26. Cholangiocarcinoma Malignant Traits Are Promoted by Schwann Cells through TGFβ Signaling in a Model of Perineural Invasion.

27. Association between gut-derived endotoxins and porto-sinusoidal vascular disorder with portal hypertension.

29. A postnatal network of co-hepato/pancreatic stem/progenitors in the biliary trees of pigs and humans.

30. Human duodenal submucosal glands contain a defined stem/progenitor subpopulation with liver-specific regenerative potential.

31. Effect of Calcium-Sulphate-Bicarbonate Water in a Murine Model of Non-Alcoholic Fatty Liver Disease: A Histopathology Study.

32. Patch grafting of organoids of stem/progenitors into solid organs can correct genetic-based disease states.

33. Role of ductular reaction and ductular-canalicular junctions in identifying severe primary biliary cholangitis.

34. Clinical relevance of biomarkers in cholangiocarcinoma: critical revision and future directions.

35. Therapeutic effects of dexamethasone-loaded hyaluronan nanogels in the experimental cholestasis.

36. Persistent biliary hypoxia and lack of regeneration are key mechanisms in the pathogenesis of posttransplant nonanastomotic strictures.

37. Islet Regeneration and Pancreatic Duct Glands in Human and Experimental Diabetes.

38. Thrombospondin 1 and 2 along with PEDF inhibit angiogenesis and promote lymphangiogenesis in intrahepatic cholangiocarcinoma.

39. Patch grafting, strategies for transplantation of organoids into solid organs such as liver.

40. Accuracy of Transient Elastography in Assessing Fibrosis at Diagnosis in Naïve Patients With Primary Biliary Cholangitis: A Dual Cut-Off Approach.

41. Molecular Landscape and Therapeutic Strategies in Cholangiocarcinoma: An Integrated Translational Approach towards Precision Medicine.

42. Metformin exerts anti-cancerogenic effects and reverses epithelial-to-mesenchymal transition trait in primary human intrahepatic cholangiocarcinoma cells.

43. DCLK1, a Putative Stem Cell Marker in Human Cholangiocarcinoma.

44. Distinct EpCAM-Positive Stem Cell Niches Are Engaged in Chronic and Neoplastic Liver Diseases.

45. Increased Liver Localization of Lipopolysaccharides in Human and Experimental NAFLD.

46. Hepatocyte Injury and Hepatic Stem Cell Niche in the Progression of Non-Alcoholic Steatohepatitis.

47. Peribiliary Gland Niche Participates in Biliary Tree Regeneration in Mouse and in Human Primary Sclerosing Cholangitis.

48. The Contribution of the Adipose Tissue-Liver Axis in Pediatric Patients with Nonalcoholic Fatty Liver Disease after Laparoscopic Sleeve Gastrectomy.

49. Matrisome analysis of intrahepatic cholangiocarcinoma unveils a peculiar cancer-associated extracellular matrix structure.

50. Peribiliary gland damage due to liver transplantation involves peribiliary vascular plexus and vascular endothelial growth factor.

Catalog

Books, media, physical & digital resources